WTA
EW icon

Washington Trust Advisors’s Edwards Lifesciences EW Stock Holding History

Washington Trust Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.7M Sell
129,607
-4,208
-3% -$353K 0.87% 28
2026
Q1 		$10.7M Sell
133,815
-4,190
-3% -$345K 0.87% 29
2025
Q4 		$11.8M Buy
138,005
+7,418
+6% +$609K 0.9% 27
2025
Q3 		$10.2M Buy
130,587
+17,625
+16% +$1.38M 0.77% 35
2025
Q2 		$8.83M Buy
112,962
+73
+0.1% +$5.44K 0.72% 38
2025
Q1 		$8.18M Sell
112,889
-521
-0.5% -$37.3K 0.73% 38
2024
Q4 		$8.4M Sell
113,410
-2,250
-2% -$157K 0.7% 40
2024
Q3 		$7.63M Buy
115,660
+23,489
+25% +$1.71M 0.66% 42
2024
Q2 		$8.51M Sell
92,171
-2,596
-3% -$230K 0.78% 36
2024
Q1 		$9.06M Sell
94,767
-2,175
-2% -$183K 0.83% 36
2023
Q4 		$7.39M Buy
96,942
+24,142
+33% +$1.68M 0.71% 40
2023
Q3 		$5.04M Buy
72,800
+86
+0.1% +$6.91K 0.52% 45
2023
Q2 		$6.86M Sell
72,714
-10
-0% -$869 0.67% 44
2023
Q1 		$6.02M Sell
72,724
-318
-0.4% -$25K 0.61% 46
2022
Q4 		$5.45M Buy
73,042
+6,450
+10% +$497K 0.6% 45
2022
Q3 		$5.5M Sell
66,592
-2,586
-4% -$249K 0.52% 52
2022
Q2 		$6.58M Sell
69,178
-4,144
-6% -$429K 0.58% 50
2022
Q1 		$8.63M Sell
73,322
-848
-1% -$95.1K 0.61% 46
2021
Q4 		$9.61M Buy
+74,170
New +$8.65M 0.65% 44

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Washington Trust Advisors's EW Position: Q2 2026 in Review

Washington Trust Advisors reduced its Edwards Lifesciences (EW) stake by 3.1% in Q2 2026, selling an estimated $353K and leaving 129,607 shares worth $11.7M. The position accounts for 0.87% of the portfolio, ranked #28.

Washington Trust Advisors first reported a position in EW in Q4 2021 and has held it in 19 quarters since. The position peaked at $11.8M in Q4 2025. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Washington Trust Advisors held 129,607 shares of Edwards Lifesciences worth $11.7M as of Q2 2026.
  • Washington Trust Advisors sold 4,208 Edwards Lifesciences shares in Q2 2026, an estimated $353K.
  • Edwards Lifesciences made up 0.87% of Washington Trust Advisors's portfolio in Q2 2026, its #28 holding.
  • Washington Trust Advisors first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 19 quarters since.
  • Washington Trust Advisors's Edwards Lifesciences position peaked at $11.8M in Q4 2025.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.